Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Akili, Inc.DNAA · Entity 89130 | Chief Financial Officer | June 29, 2021 | June 29, 2021 |
| PROKIDNEY CORP.DNAC · Entity 5181 | Chief Financial Officer | June 29, 2021 | June 30, 2021 |
| Social Capital Hedosophia Holdings Corp. IVIPOD · Entity 134457 | Chief Financial Officer | May 31, 2021 | October 19, 2021 |
| Social Capital Hedosophia Holdings Corp. VIIPOF · Entity 134562 | Chief Financial Officer | May 31, 2021 | October 15, 2021 |
| Social Capital Suvretta Holdings Corp. IIDNAB · Entity 125597 | Chief Financial Officer | June 29, 2021 | June 29, 2021 |
| Social Capital Suvretta Holdings Corp. IVDNAD · Entity 123913 | Chief Financial Officer | June 29, 2021 | June 29, 2021 |
| Virgin Galactic Holdings, IncSPCE · Entity 5565 | Director | December 16, 2020 | December 18, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Akili, Inc.
Report date June 29, 2021 · Filed June 29, 2021
This filing explicitly reported no securities owned.
PROKIDNEY CORP.
Report date June 29, 2021 · Filed June 30, 2021
This filing explicitly reported no securities owned.
Social Capital Hedosophia Holdings Corp. IV
Report date May 31, 2021 · Filed October 19, 2021
This filing explicitly reported no securities owned.
Social Capital Hedosophia Holdings Corp. VI
Report date May 31, 2021 · Filed October 15, 2021
This filing explicitly reported no securities owned.
Social Capital Suvretta Holdings Corp. II
Report date June 29, 2021 · Filed June 29, 2021
This filing explicitly reported no securities owned.
Social Capital Suvretta Holdings Corp. IV
Report date June 29, 2021 · Filed June 29, 2021
This filing explicitly reported no securities owned.
Virgin Galactic Holdings, Inc
Report date December 16, 2020 · Filed December 18, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 103,346 |
Reported balance
After 2020-12-16 transaction · row 1
1 source rowRow 1 · 2020-12-16 · Sale · Disposed 30,000 · Balance 103,346 F1: Represents the number of shares of common stock the reporting person sold to satisfy the reporting person's tax withholding obligation upon the October 2020 vesting of Restricted Stock Units. F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at price ranging from $26.30 to $26.80. The reporting person undertakes to provide Virgin Galactic Holdings, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares of common stock the reporting person sold to satisfy the reporting person's tax withholding obligation upon the October 2020 vesting of Restricted Stock Units.
F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at price ranging from $26.30 to $26.80. The reporting person undertakes to provide Virgin Galactic Holdings, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CLOVER HEALTH INVESTMENTS, CORP. /DE
Report date January 07, 2021 · Filed January 11, 2021
Section 16 reporting ended · disclosed 2021-01-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 100,000 |
Reported balance
After 2021-01-07 transaction · row 1
1 source rowRow 1 · 2021-01-07 · Exercise / conversion · Acquired 100,000 · Balance 100,000 F1: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one share of the Issuer's Class A common stock, par value $0.0001 per share. |
| Class B ordinary shareSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-01-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-01-07 · Exercise / conversion · Disposed 100,000 · Balance 0 F1: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one share of the Issuer's Class A common stock, par value $0.0001 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one share of the Issuer's Class A common stock, par value $0.0001 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 07, 2021 Filed Jan 11, 2021 18:18 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Exercise / conversionClass B ordinary share · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-001383 · doc4.xml · derivative · entry 2 Ryans James · CIK 0001724596 · FORMER DIRECTOR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 100,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one share of the Issuer's Class A common stock, par value $0.0001 per share. F1 · derivative.exercise_date: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one share of the Issuer's Class A common stock, par value $0.0001 per share. F1 · derivative.expiration_date: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one share of the Issuer's Class A common stock, par value $0.0001 per share. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 18:18 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Exercise / conversionClass A Common Stock | 100,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-001383 · doc4.xml · nonDerivative · entry 1 Ryans James · CIK 0001724596 · FORMER DIRECTOR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On January 7, 2021, the Social Capital Hedosophia Holdings Corp. III ("SCH" and the former name of the Issuer) consummated its initial business combination (the "Business Combination") with Clover Health Investments, Corp. In connection with the consummation of the Business Combination, each share of Class B ordinary share, par value $0.0001 per share, of SCH automatically converted into one share of the Issuer's Class A common stock, par value $0.0001 per share. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 21:15 UTC | Virgin Galactic Holdings, Inc SPCE · Entity 5565 | SaleCommon Stock | 30,000 | $26.43 | $792,900.00 |
DisclosureSEC source: 0001706946-20-000065 · wf-form4_160832610891059.xml · nonDerivative · entry 1 Ryans James · CIK 0001724596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,346 F1 · shares: Represents the number of shares of common stock the reporting person sold to satisfy the reporting person's tax withholding obligation upon the October 2020 vesting of Restricted Stock Units. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at price ranging from $26.30 to $26.80. The reporting person undertakes to provide Virgin Galactic Holdings, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 20:50 UTC | Virgin Galactic Holdings, Inc SPCE · Entity 5565 | GrantCommon stock | 7,901 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-008991 · wf-form4_159130381633997.xml · nonDerivative · entry 1 Ryans James · CIK 0001724596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,346 F1 · shares: Represents an award of restricted stock units, which vests in full on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the Issuer's next annual meeting of stockholders following the grant date, subject to continued service through the applicable vesting date. The restricted stock units will be settled in shares of the Issuer's common stock upon vesting. Read SEC document |
| December 30, 2019 Filed Jan 3, 2020 01:22 UTC | Virgin Galactic Holdings, Inc SPCE · Entity 5565 | GrantCommon Stock | 25,445 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-000156 · doc4.xml · nonDerivative · entry 1 Ryans James · CIK 0001724596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,445 F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments beginning on October 25, 2020, subject to the director's continued service. The restricted stock units will be settled in shares of the Issuer's common stock upon vesting. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 00:48 UTC | Virgin Galactic Holdings, Inc SPCE · Entity 5565 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-026173 · doc4.xml · nonDerivative · entry 1 Ryans James · CIK 0001724596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.